Pharmacists can continue making compounded versions of generic tirzepatide, the active ingredient in popular medications ...

A trade organization representing compounding pharmacies that make unbranded versions of the weight loss drugs Mounjaro and ...

The U.S. Food and Drug Administration on Friday agreed to reconsider a decision it made last month to bar drug compounders ...

We're living in the era of Ozempic. For others, however, the accessibility has led to misuse. "We have a little bit of a wild west in who's writing for this medication now, because it is so ...

Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...

They also agree that the FDA has latitude to tread lightly on enforcement as the tirzepatide market settles ... Manufacturers and repackers have until May 28, 2025; wholesale distributors have until ...

copied versions of the medications by ordering ingredients in bulk and producing the medications themselves. But when the FDA announced on Oct. 2 that the shortage of tirzepatide had ended ...

On Oct. 2, the FDA announced that the nearly two-year-long shortage of tirzepatide ... prescription-specific compounded drugs as well as bulk orders. The OFA and the compounding pharmacy North ...